pirfenidone has been researched along with Actinic Reticuloid Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, Y; Kitamura, S; Seo, T; Ujiie, H; Yanagi, T; Yoshimoto, N | 1 |
| Oku, H; Tokura, T; Tsukamoto, Y | 1 |
| Antoniu, SA | 1 |
1 review(s) available for pirfenidone and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Cell Line; Clinical Trials, Phase II as Topic; Connective Tissue Growth Factor; Cricetinae; Cyclophosphamide; Drug Evaluation, Preclinical; Drugs, Investigational; Fibroblasts; Hermanski-Pudlak Syndrome; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lung Transplantation; Mice; Orphan Drug Production; Photosensitivity Disorders; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Scleroderma, Systemic; Transforming Growth Factor beta; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
2 other study(ies) available for pirfenidone and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Multiple actinic keratosis on the face associated with pirfenidone-induced photosensitivity.
Topics: Humans; Keratosis, Actinic; Photosensitivity Disorders; Pyridones | 2022 |
[Pharmacological properties and clinical effects of the antifibrotic agent pirfenidone (Pirespa) for treatment of idiopathic pulmonary fibrosis].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Gastrointestinal Diseases; Humans; Idiopathic Pulmonary Fibrosis; Photosensitivity Disorders; Pyridones; Skin Neoplasms | 2009 |